« Max Gergel's Memoirs |
| Scientific Discovery: Getting Older (And Less Lonely) »
May 27, 2010
Pfizer Halts a Trial Early - On Good News
Pfizer was able to announce some good news today - their trial of Inspra (eplerenone) for patients with a particular combination of heart failure symptoms. The trial was halted early, but (for once) because the endpoints were reached so early that it would have been unethical to continue the placebo arm. It's always nice to hear about one of those; we don't get them that often.
The drug is an aldosterone antagonist which had already been approved several years ago for heart failure and hypertension, so it's not really a surprise that it worked in this population. But you never know, and Pfizer wanted to be able to get specifically recommended for patients of this type. And that they will.
+ TrackBacks (0) | Category: Cardiovascular Disease | Clinical Trials
POST A COMMENT
- RELATED ENTRIES
- Always Insist on Error Bars
- Startups vs. Big Pharma
- A Blood Test for Alzheimer's?
- Repurposing for Cervical Cancer
- Some New Reviews
- A Structure From the Molecular Sponge
- Biggest US Cities for Biopharma Funding, Versus Whole Continents.
- We Are Pleased To Publish Your Senseless Ravings